Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer

Clinical trial NCT00436254 · COMPLETED

Trial details

NCT number: NCT00436254
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HER2-positive Breast Cancer Stage III Ovarian Epithelial Cancer Stage III Ovarian Germ Cell Tumor Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Stage IV Ovarian Epithelial Cancer Stage IV Ovarian Germ Cell Tumor

Start date: 2001-10-01
Primary completion: 2010-03-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.